Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Heck Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102414198B details a high-purity synthesis route for Eletriptan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN119504740A details a cost-effective Palbociclib synthesis. Enhances supply chain reliability and purity for pharmaceutical manufacturers.
Novel ionic liquid-mediated Heck coupling for trans-resveratrol. High yield, green process, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112209951B details a novel BDTT-bi-Cd dye sensitizer achieving 8.40% efficiency. Discover scalable synthesis routes for optoelectronic materials.
Patent CN111943965A reveals a high-efficiency BDTT-im-Cd dye sensitizer with 9.13% PCE. Discover scalable synthesis and thermal stability advantages for DSSC manufacturing.
Novel palladium-catalyzed route for bilastine intermediates ensures high yield and safety. Reliable supplier for pharmaceutical manufacturing cost reduction.
Patent CN101781189A details a water-based Heck reaction using supported Pd catalyst for high-yield cinnamic acid production, offering significant cost and environmental advantages.
Patent CN108440759B details a novel Heck coupling route for fluorescent POSS monomers, offering enhanced thermal stability and cost reduction in electronic chemical manufacturing.
Patent CN108440759B details a novel Heck coupling route for carbazolyl POSS monomers, offering superior thermal stability and fluorescence for optoelectronic supply chains.
Patent CN102964334B details a novel Heck-reduction route for 2-thiopheneethanol, offering mild conditions and high purity for cardiovascular drug intermediates.
Patent CN104829460A reveals a cost-effective asymmetric reductive amination route for cinacalcet hydrochloride, offering high purity and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN115784839B details a cost-effective Heck coupling route for Siponimod intermediates, offering scalable manufacturing and enhanced supply chain reliability.
Advanced process for CNS drug intermediates via optimized Pd-coupling. Enhances yield and scalability for cost reduction in API manufacturing.
Patent CN102311381A details a high-purity Heck coupling method for Acrivastine precursors, offering superior selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN102503763A details a high-selectivity Heck reaction for stilbene synthesis. This method offers superior regioselectivity and yield for reliable pharmaceutical intermediates supply.
Innovative 11-step synthetic route for high-purity H4 alkaloid ensures scalable supply for NAFLD therapeutics, overcoming natural extraction limitations effectively.
Patent CN102010279A details a rapid, green method for aryl ethylene derivatives using PEG-400 and PdCl2, offering significant cost and time advantages for pharmaceutical intermediate manufacturing.
Patent CN101052633A details efficient indazole synthesis for kinase inhibitors. Discover cost reduction in API manufacturing and scalable production methods.
Discover the novel Cytosine-based route for Palbociclib parent nucleus. Enhanced purity, reduced costs, and scalable manufacturing for global supply chains.
Patent CN103724239A reveals a high-yield two-step route for Belinostat intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.